Houston, NY
Peptide Therapy clinics in Houston
Houston has the Texas Medical Center footprint and an energy industry workforce that prioritizes performance medicine, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across River Oaks, The Heights, Memorial, and Katy range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Houston Methodist, MD Anderson, and Memorial Hermann network. The scene here skews toward a mix of physician-owned longevity practices and nurse-directed medspas. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Houston clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
No clinics found
Reset all filtersRegulatory context
A note on New York's peptide therapy rules.
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, restricting 503A pharmacy sourcing. Section 503A covers traditional patient-specific compounding; Section 503B covers FDA-registered outsourcing facilities held to cGMP.
-
New York Education Law Article 137 (Pharmacy)
Governs pharmacy licensure and compounding under the New York State Board of Pharmacy within the Office of the Professions. -
New York Education Law Article 131 (Medicine)
Regulates physician practice and prescribing. -
10 NYCRR Part 80 and 8 NYCRR Part 63
Set New York compounding and controlled substance standards.
New York operates pharmacy regulation under the State Education Department's Office of the Professions (licensure) and the Department of Health Bureau of Narcotic Enforcement (controlled substances and dangerous drugs). Non-resident pharmacies shipping peptides into New York must hold a current New York registration. Enforcement against unlicensed compounding and improper bulk sourcing is active.
Peptide Therapy in Houston, answered.
Explore related care